+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Allergy relieving Eye Drops Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4851571
  • Report
  • January 2019
  • Region: Global
  • 175 pages
  • Transparency Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

Allergy-relieving Eye Drops Market: Overview

This report analyzes the current and future scenario of the global allergy-relieving eye drops market for the period 2018 to 2026. Rise in geriatric population, increased prevalence of ocular disorders, and high unmet medical needs are likely to be major drivers of the global allergy-relieving eye drops market during the forecast period.

The allergy-relieving eye drops market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on drug class, type, distribution channel, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the allergy-relieving eye drops market.

Allergy-relieving Eye Drops Market: Key Segments

Based on drug class, the global allergy-relieving eye drops market has been segmented into antihistamines, non-steroidal anti-inflammatory drugs, vasoconstrictors, and others. The segments have been analyzed based on available drugs used for the treatment of allergic conjunctivitis. Based on type, the market has been classified into seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, giant papillary conjunctivitis, and others. In terms of distribution channel, the global allergy-relieving eye drops market has been divided into hospital pharmacies, retail, and online sales. Based on market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.

Allergy-relieving Eye Drops Market: Regional Outlook

In terms of region, the global allergy-relieving eye drops market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report

The report also profiles major players operating in the global allergy-relieving eye drops market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Allergan Plc., Johnson & Johnson Services, Inc., Pfizer, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., and Santen Pharmaceutical Co., Ltd.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Allergy-relieving Eye Drops Market

4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Allergy-relieving Eye Drops Market Analysis and Forecast, 2016-2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis

5. Market Outlook
5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
5.2. Pipeline Analysis
5.3. Regulatory Scenario by Region

6. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016-2026
6.3.1. Antihistamines
6.3.2. Non-steroidal Anti-inflammatory Drugs
6.3.3. Vasoconstrictors
6.3.4. Others
6.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Drug Class

7. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016-2026
7.3.1. Seasonal and Perennial Allergic Conjunctivitis
7.3.2. Vernal Keratoconjunctivitis
7.3.3. Atopic Keratoconjunctivitis
7.3.4. Giant Papillary Conjunctivitis
7.3.5. Others
7.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Type

8. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016-2026
8.3.1. Hospital Pharmacies
8.3.2. Retail
8.3.3. Online Sales
8.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel

9. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Allergy-relieving Eye Drops Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Allergy-relieving Eye Drops Market Attractiveness, by Country/Region

10. North America Allergy-relieving Eye Drops Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016-2026
10.2.1. Antihistamines
10.2.2. Non-steroidal Anti-inflammatory Drugs
10.2.3. Vasoconstrictors
10.2.4. Others
10.3. North America Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016-2026
10.3.1. Seasonal and Perennial Allergic Conjunctivitis
10.3.2. Vernal Keratoconjunctivitis
10.3.3. Atopic Keratoconjunctivitis
10.3.4. Giant Papillary Conjunctivitis
10.3.5. Others
10.4. North America Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016-2026
10.4.1. Hospital Pharmacies
10.4.2. Retail
10.4.3. Online Sales
10.5. North America Allergy-relieving Eye Drops Market Value Forecast, by Country, 2016-2026
10.5.1. US
10.5.2. Canada
10.6. North America Allergy-relieving Eye Drops Market Attractiveness Analysis
10.6.1. By Drug Class
10.6.2. By Type
10.6.3. By Distribution Channel
10.6.4. By Country

11. Europe Allergy-relieving Eye Drops Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016-2026
11.2.1. Antihistamines
11.2.2. Non-steroidal Anti-inflammatory Drugs
11.2.3. Vasoconstrictors
11.2.4. Others
11.3. Europe Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016-2026
11.3.1. Seasonal and Perennial Allergic Conjunctivitis
11.3.2. Vernal Keratoconjunctivitis
11.3.3. Atopic Keratoconjunctivitis
11.3.4. Giant Papillary Conjunctivitis
11.3.5. Others
11.4. Europe Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016-2026
11.4.1. Hospital Pharmacies
11.4.2. Retail
11.4.3. Online Sales
11.5. Europe Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016-2026
11.5.1. Germany
11.5.2. France
11.5.3. U.K.
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Allergy-relieving Eye Drops Market Attractiveness Analysis
11.6.1. By Drug Class
11.6.2. By Type
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region

12. Asia Pacific Allergy-relieving Eye Drops Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016-2026
12.2.1. Antihistamines
12.2.2. Non-steroidal Anti-inflammatory Drugs
12.2.3. Vasoconstrictors
12.2.4. Others
12.3. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016-2026
12.3.1. Seasonal and Perennial Allergic Conjunctivitis
12.3.2. Vernal Keratoconjunctivitis
12.3.3. Atopic Keratoconjunctivitis
12.3.4. Giant Papillary Conjunctivitis
12.3.5. Others
12.4. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016-2026
12.4.1. Hospital Pharmacies
12.4.2. Retail
12.4.3. Online Sales
12.5. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016-2026
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Allergy-relieving Eye Drops Market Attractiveness Analysis
12.6.1. By Drug Class
12.6.2. By Type
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region

13. Latin America Allergy-relieving Eye Drops Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016-2026
13.2.1. Antihistamines
13.2.2. Non-steroidal Anti-inflammatory Drugs
13.2.3. Vasoconstrictors
13.2.4. Others
13.3. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016-2026
13.3.1. Seasonal and Perennial Allergic Conjunctivitis
13.3.2. Vernal Keratoconjunctivitis
13.3.3. Atopic Keratoconjunctivitis
13.3.4. Giant Papillary Conjunctivitis
13.3.5. Others
13.4. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016-2026
13.4.1. Hospital Pharmacies
13.4.2. Retail
13.4.3. Online Sales
13.5. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016-2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Allergy-relieving Eye Drops Market Attractiveness Analysis
13.6.1. By Drug Class
13.6.2. By Type
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region

14. Middle East & Africa Allergy-relieving Eye Drops Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016-2026
14.2.1. Antihistamines
14.2.2. Non-steroidal Anti-inflammatory Drugs
14.2.3. Vasoconstrictors
14.2.4. Others
14.3. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016-2026
14.3.1. Seasonal and Perennial Allergic Conjunctivitis
14.3.2. Vernal Keratoconjunctivitis
14.3.3. Atopic Keratoconjunctivitis
14.3.4. Giant Papillary Conjunctivitis
14.3.5. Others
14.4. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016-2026
14.4.1. Hospital Pharmacies
14.4.2. Retail
14.4.3. Online Sales
14.5. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region 2016-2026
14.5.1. GCC Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness Analysis
14.6.1. By Drug Class
14.6.2. By Type
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region

15. Competition Landscape
15.1. Global Allergy-relieving Eye Drops Market Share Analysis, by Company (2016)
15.2. Company Profiles
15.2.1. Allergan plc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. SWOT Analysis
15.2.1.4. Financial Overview
15.2.1.5. Strategic Overview
15.2.2. Novartis AG
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. SWOT Analysis
15.2.2.4. Financial Overview
15.2.2.5. Strategic Overview
15.2.3. Johnson & Johnson Services, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. SWOT Analysis
15.2.3.4. Financial Overview
15.2.3.5. Strategic Overview
15.2.4. Pfizer, Inc.
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. SWOT Analysis
15.2.4.4. Financial Overview
15.2.4.5. Strategic Overview
15.2.5. F. Hoffmann-La Roche Ltd.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. SWOT Analysis
15.2.5.4. Financial Overview
15.2.5.5. Strategic Overview
15.2.6. Bausch Health Companies Inc.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. SWOT Analysis
15.2.6.4. Financial Overview
15.2.6.5. Strategic Overview
15.2.7. Regeneron Pharmaceuticals, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. SWOT Analysis
15.2.7.4. Financial Overview
15.2.7.5. Strategic Overview
15.2.8. Santen Pharmaceutical Co., Ltd.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. SWOT Analysis
15.2.8.4. Financial Overview
15.2.8.5. Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll